Zenerchi Overview

  • Founded
  • 2019
Founded
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • (Cancelled)
  • Investors
  • 1

Zenerchi General Information

Description

Developer of a human body simulator and AI cloud platform designed to create visualization capabilities. The company's simulators have 3D/4D/VR/AR visualization that will provide cloud-based applied understanding of human physiology, enabling healthcare professionals to serve better and create visualization capabilities far beyond current technology realm.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Outcome Management (Healthcare)
Other Industries
Diagnostic Equipment
Primary Office
  • 7984 South 1300 East
  • Sandy, UT 84094
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Zenerchi Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 30-Oct-2019 Cancelled Generating Revenue
1. Seed Round 30-Oct-2019 00.000 00.000 Completed Generating Revenue
To view Zenerchi’s complete valuation and funding history, request access »

Zenerchi Executive Team (3)

Name Title Board Seat Contact Info
Bryan Brandenburg Co-Founder, Chief Executive Officer, Chairman, Chief Scientific Officer
Carlos Justiniano Co-Founder & Vice President of IoT and Cloud Platforms
Hung Nguyen Co-Founder & Vice President of Software Engineering, Vietnam
To view Zenerchi’s complete executive team members history, request access »

Zenerchi Board Members (2)

Name Representing Role Since
Brandon Fugal Self Board Member 000 0000
Rod Turner Self Board Member 000 0000
To view Zenerchi’s complete board members history, request access »

Zenerchi Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Dinesh Patel Angel (individual) Minority 000 0000 000000 0
To view Zenerchi’s complete investors history, request access »